PureTech Founded Entity Seaport Therapeutics Adds Intra-Cellular Therapies Founder and CEO, Dr. Sharon Mates, to its Board of Directors
Go back to PureTech Founded Entity Seaport Therapeutics Adds Intra-Cellular Therapies Founder and CEO, Dr. Sharon Mates, to its Board of Directors| (NASDAQ: BNTC) | Delayed: 13.63 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.63 | 52 Week High | $5.64 | |||
| Open | $13.63 | 52 Week Low | $1.20 | |||
| Day High | $13.63 | P/E | N/A | |||
| Day Low | $13.63 | EPS | $0.00 | |||
| Volume | 22 | |||||
| (NASDAQ: PRTC) | Delayed: 17.42 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $17.42 | 52 Week High | $ | |||
| Open | $17.42 | 52 Week Low | $ | |||
| Day High | $17.42 | P/E | N/A | |||
| Day Low | $17.42 | EPS | $ | |||
| Volume | 7,198 | |||||
| (NASDAQ: PRTC) | Delayed: 17.42 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $17.42 | 52 Week High | $ | |||
| Open | $17.42 | 52 Week Low | $ | |||
| Day High | $17.42 | P/E | N/A | |||
| Day Low | $17.42 | EPS | $ | |||
| Volume | 7,198 | |||||

